{
    "code": 0,
    "data": [
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Board Comments On The Fine Levied By The Exchange",
            "news_body": "Board Comments on the fine levied by the Exchange\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=186a7c15-4f2f-4599-8ba0-2d8b4b1069d0.pdf",
            "news_date": "2026-02-12 19:06:56"
        },
        {
            "sym": "AAREYDRUGS",
            "disp": "Aarey Drugs & Pharmaceuticals",
            "bse_code": 524412,
            "isin": "INE198H01019",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended 31St December 2025",
            "news_body": "Approval of Unaudited Financial Results for the quarter ended 31st December 2025",
            "news_id": "169617be-9353-4515-87cf-0117596b659d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d76a41ad-3bef-4a66-be42-1a020a8550a5.pdf",
            "news_date": "2026-02-11 18:57:58",
            "seo": "aarey-drugs-pharm-ltd",
            "ltp": 67.97,
            "ch": 2.6400000000000006,
            "pch": 4.041022501148019,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 5245,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended 31St December 2025",
            "news_body": "Approval of Unaudited Financial Results for the quarter ended 31st December 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d76a41ad-3bef-4a66-be42-1a020a8550a5.pdf",
            "news_date": "2026-02-11 18:57:58"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On Today I.E 11Th February 2026.",
            "news_body": "This is to inform you that the Board of Directors of the Company at its Meeting held today i.e. 11th February 2026 have passed the following resolution.\r\n1. The Board of Directors of the Company has considered and approved the Unaudited Financial Results for the quarter ended 31st December 2025 along with the Limited Review Report Report MD/CFO certification.\r\n*Company segment is single",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5392a051-a7c2-45ca-b211-0f9f7b746438.pdf",
            "news_date": "2026-02-11 18:49:08"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Board Meeting Intimation",
            "news_body": "Aarey Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 inter alia to consider and approve This is to intimate that the meeting of the Board of Directors of the Company is scheduled to be held on Wednesday11th February 2026 to transact the following business: \r\n\r\n1. To consider and approve the Unaudited Financial Result along with Limited review Report for the quarter ended 31st December 2025. \r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=59bf3ed2-0c13-441d-84a6-0e03804ef353.pdf",
            "news_date": "2026-02-04 16:59:48"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Certificate under reg 74(5) of SEBI (Depositories and Participants) Regulations 2018",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1a8b9eb6-f161-4ece-bb66-60c823094e93.pdf",
            "news_date": "2026-01-14 18:32:18"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation for Closure of Trading Window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f244185c-fff0-4f3e-bad1-1f478c0d46b3.pdf",
            "news_date": "2025-12-30 12:31:07"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication of the Unaudited Financial Results",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4116931a-f02f-4807-b4ad-e9c140f2dd87.pdf",
            "news_date": "2025-11-15 18:12:42"
        },
        {
            "sym": "AAREYDRUGS",
            "disp": "Aarey Drugs & Pharmaceuticals",
            "bse_code": 524412,
            "isin": "INE198H01019",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter & Half Year Ended On 30Th Sept 2025",
            "news_body": "Approval of Unaudited Financial results for the quarter & half year ended on 30th Sept 2025",
            "news_id": "0ef9bb15-3a05-4e2b-87a2-a1485578de92",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d99ee85b-8f14-4a22-a795-d37a95a179ad.pdf",
            "news_date": "2025-11-13 20:50:06",
            "seo": "aarey-drugs-pharm-ltd",
            "ltp": 67.97,
            "ch": 2.6400000000000006,
            "pch": 4.041022501148019,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 5245,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter & Half Year Ended On 30Th Sept 2025",
            "news_body": "Approval of Unaudited Financial results for the quarter & half year ended on 30th Sept 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d99ee85b-8f14-4a22-a795-d37a95a179ad.pdf",
            "news_date": "2025-11-13 20:50:06"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 13Th November 2025",
            "news_body": "Outcome of Board meeting for approval of Unaudited Financial Results for the quarter and half year ended 30th September 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=945d7e82-8192-42e0-ab58-510a46e143e1.pdf",
            "news_date": "2025-11-13 20:44:45"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Intimation Of Board Meeting.",
            "news_body": "Aarey Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 inter alia to consider and approve This is to intimate that the meeting of the Board of Directors of the Company is scheduled to be held on Thursday 13th November 2025 to transact the following business:\r\n1. To consider and approve the Unaudited Financial Result along with Limited review Report for the quarter and half year ended 30th September 2025.\r\n2. Any other matter with consent of the Chairman.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d08aad70-bb3f-42be-a381-2b642b986b9c.pdf",
            "news_date": "2025-11-08 15:38:53"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Certificate under regulation 74(5) of SEBI (Depository and Participants) Regulations 2018 for the quarter and half year ended 30th September 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e7f1d89e-0ead-407f-80b3-42fa4120152b.pdf",
            "news_date": "2025-10-08 14:28:45"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
            "news_body": "Disclosure on Voting Results along with Consolidated Scrutinizers Report of 35th Annual General Meeting of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b8b2b39b-53b2-461c-ab37-95a2d9bfac28.pdf",
            "news_date": "2025-10-01 19:55:26"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Closure of Trading Window for the Quarter and half year ended 30 September 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a47f9869-3c79-402e-b23d-2cd1aa9d8b59.pdf",
            "news_date": "2025-09-29 20:19:17"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
            "news_body": "AGM Proceedings of the 35th Annual General Meeting of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d2ce2488-03aa-472f-aa69-5177bcd80cd2.pdf",
            "news_date": "2025-09-29 18:40:18"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Corrigendum To The Integrated Annual Report For FY 2024-25",
            "news_body": "Corrigendum to the integrated Annual Report for FY 2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fa21387b-4d18-4caf-b1de-330ca0645a76.pdf",
            "news_date": "2025-09-24 17:09:46"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e057db0b-0c03-4845-a278-823d41ffbdd7.pdf",
            "news_date": "2025-09-12 18:49:20"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "Notice and Integrated Annual Report for 35th Annual General Meeting of Company as required under\r\nRegulation 34(1)",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=92f6cf66-a1e9-487e-a5f9-9ad0086c8122.pdf",
            "news_date": "2025-09-06 19:43:01"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Intimation",
            "descriptor": "AGM",
            "caption": "Notice Of 35Th Annual General Meeting Of The Company For The Financial Year 2024-25",
            "news_body": "Notice of 35th Annual General Meeting of the company for the financial year 2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=347fd627-3196-4ca5-a772-1b34ca4ee195.pdf",
            "news_date": "2025-09-06 19:37:46"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Intimation",
            "descriptor": "Book Closure",
            "caption": "Intimation Of Book Closure",
            "news_body": "INTIMATION OF BOOK CLOSURE",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=de597608-0d0a-43c6-84d7-c286f528e011.pdf",
            "news_date": "2025-09-06 19:34:39"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Revised Outcome Of Board Meeting Held On 03Rd September 2025",
            "news_body": "With reference to the Outcome submitted yesterday i.e. on 03.09.2025 we would like to clarify that due to inadvertent error in Point No. 2 of the Outcome the time of the Annual General Meeting was mentioned as 11:00 P.M. instead of 11:00 A.M.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7dbcd3e3-fa07-440c-86e3-74779a5c29f2.pdf",
            "news_date": "2025-09-04 20:25:46"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Please find enclosed Disclosure",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2f5529cd-db04-494e-8cf6-59bd8375511c.pdf",
            "news_date": "2025-09-03 20:15:06"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Outcome",
            "descriptor": "Outcome without intimation",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 03\" September 2025",
            "news_body": "Pursuant to Regulation 30 (read with Part A of Schedule 1ll) and Regulation 33 of the SEBI (Listing\r\nObligations and Disclosure Requirements) Regulations 2015 (\"Listing Regulations\") we wish to\r\ninform you that a meeting of the Board of Directors of the Company was held today i.e.\r\nWednesday 03\" September 2025 at 05:00 P.M. at the registered office of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=512dec9c-ad90-4437-b29c-4fbe8b8d36c0.pdf",
            "news_date": "2025-09-03 20:10:40"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=87bc69f1-3352-43ca-b49b-c947d5970a17.pdf",
            "news_date": "2025-08-18 16:39:04"
        },
        {
            "sym": "AAREYDRUGS",
            "disp": "Aarey Drugs & Pharmaceuticals",
            "bse_code": 524412,
            "isin": "INE198H01019",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended 30Th June 2025 Along With The Limited Review Report MD/CFO Certification.",
            "news_body": "Unaudited Financial Results for the quarter ended 30th June 2025 along with the Limited Review Report MD/CFO Certificate",
            "news_id": "2dad40b3-51c7-48e6-9d9e-8d637ff62476",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1ecca3b3-c285-4418-a86c-f4b147059f42.pdf",
            "news_date": "2025-08-13 17:41:32",
            "seo": "aarey-drugs-pharm-ltd",
            "ltp": 67.97,
            "ch": 2.6400000000000006,
            "pch": 4.041022501148019,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 5245,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended 30Th June 2025 Along With The Limited Review Report MD/CFO Certification.",
            "news_body": "Unaudited Financial Results for the quarter ended 30th June 2025 along with the Limited Review Report MD/CFO Certificate",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1ecca3b3-c285-4418-a86c-f4b147059f42.pdf",
            "news_date": "2025-08-13 17:41:32"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On Today I.E 13Th August 2025",
            "news_body": "Outcome of Board Meeting held on today i.e 13th August 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=20c9ed9b-c350-4e8f-a672-dad7844c9d69.pdf",
            "news_date": "2025-08-13 17:33:49"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Intimation Of Board Meeting",
            "news_body": "Aarey Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 inter alia to consider and approve This is to intimate that the meeting of the  Board of Directors of the Company is scheduled to be held on Wednesday 13th August 2025 to  transact the following business:\r\n\r\n1. To consider and approve the Unaudited Financial Result along with Limited review   Report for the First quarter ended 30th June 2025.\r\n2. Any other matter with consent of the Chairman.\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d1c66731-800a-46b3-887e-361fd8671b0f.pdf",
            "news_date": "2025-08-07 13:08:37"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Revised Filing Of Audited Financial Results For The Year Ended 31St March 2025",
            "news_body": "Revised filing of Audited Financial Results for the year ended 31st March 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e17e26ec-5a47-477c-b35a-18bfae4d07ed.pdf",
            "news_date": "2025-07-30 19:08:06"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Certificate under Regulation 74(5) of SEBI (Depositories And Participants) Regulations 2018 for the quarter ended 30th June 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6fa40c0e-de78-4b62-a3fa-d28afb856cdd.pdf",
            "news_date": "2025-07-10 18:20:01"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation for Closure of Trading Window for Quarter Ended June 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e0869110-4160-4bd6-879c-30ce31651e00.pdf",
            "news_date": "2025-06-24 15:09:08"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Submission of Newspaper copies of publication of Audited Financial Results of the company for the quarter and year ended on 31st March 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0dfcc557-4415-4b8e-8d5e-1145b6d426db.pdf",
            "news_date": "2025-06-03 16:07:36"
        },
        {
            "sym": "AAREYDRUGS",
            "disp": "Aarey Drugs & Pharmaceuticals",
            "bse_code": 524412,
            "isin": "INE198H01019",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Reg. 33 - Audited Financial Results For The Quarter & Financial Year Ended 31St March 2025",
            "news_body": "Audited Financial Result For the year ended on 31st March 2025",
            "news_id": "d2d571ae-9ede-4ae1-bd62-5ef1173ec19a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0b3c9058-b51d-4da6-b00a-370478ddb2c7.pdf",
            "news_date": "2025-05-30 22:17:38",
            "seo": "aarey-drugs-pharm-ltd",
            "ltp": 67.97,
            "ch": 2.6400000000000006,
            "pch": 4.041022501148019,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 5245,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Reg. 33 - Audited Financial Results For The Quarter & Financial Year Ended 31St March 2025",
            "news_body": "Audited Financial Result For the year ended on 31st March 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0b3c9058-b51d-4da6-b00a-370478ddb2c7.pdf",
            "news_date": "2025-05-30 22:17:38"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On Friday I.E 30Th May 2025",
            "news_body": "This is to inform you that the Board of Directors of the Company at its Meeting held today i.e. 30th May 2025 have passed the following resolution.\r\n1. The Board of Directors of the Company has considered and approved the Standalone Audited Financial Results for the quarter and year ended 31st March 2025 along with the Statement of Asset and Liabilities Result Cash flow Audit Report declaration on unmodified opinion MD/CFO certification.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=53c4a2f5-8d1a-4701-a077-90b53ebc9758.pdf",
            "news_date": "2025-05-30 22:07:10"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Compliance",
            "descriptor": "Reg.24(A)-Annual Secretarial Compliance",
            "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
            "news_body": "Annual secretarial Compliance Report  for the year ended on 31st March 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e5428379-4a20-4c5a-bafe-1e4a6c2f2131.pdf",
            "news_date": "2025-05-30 18:20:30"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of Equity Shares",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment",
            "news_body": "Allotment of Convertible Warrants pursuant to Preferential Issue.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4713b905-2305-4330-9664-e65be7793b40.pdf",
            "news_date": "2025-05-23 14:30:17"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Board Meeting Intimation",
            "news_body": "Aarey Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 inter alia to consider and approve This is to intimate that the meeting of the  Board of Directors of the Company is scheduled to be held on Friday 30th May 2025 to  transact the following business:\r\n1. To consider and approve the Audited Financial statement for the quarter and year ended 31st March 2025.\r\n2. Any other matter with consent of the Chair\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=23f5870d-8d9e-43cf-9ae1-deba6b8fc474.pdf",
            "news_date": "2025-05-22 16:56:38"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Reg 30 Of SEBI LODR",
            "news_body": "Reg 30 of SEBI LODR",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=34d69e82-75d8-4c27-8d33-56daf7ee3815.pdf",
            "news_date": "2025-05-08 14:23:12"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Certificate under Regulation 74(5) of the SEBI (Depositories and Participants)  Regulations 2018 for the quarter ended March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2c7f1366-9d52-4d8a-8031-1bf424546937.pdf",
            "news_date": "2025-04-11 12:52:35"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Clarification On Price Movement",
            "news_body": "Clarification on Price Movement",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=900ce80f-b861-4e26-a9d2-d9f1dc8db9a0.pdf",
            "news_date": "2025-04-09 16:34:58"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "General",
            "descriptor": "Clarification",
            "caption": "Clarification sought from Aarey Drugs & Pharmaceuticals Ltd",
            "news_body": "The Exchange has sought clarification from Aarey Drugs & Pharmaceuticals Ltd on April 7 2025 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.",
            "file_url": "",
            "news_date": "2025-04-07 17:55:45"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation for the closure of Trading window as per SEBI PIT Regulations trading window for dealing in securities will be closed for all the officers and designated employees effective from 1st April 2025 till 48 hours after declaration of Audited Financial results for the quarter and year ended as on 31st March 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f5698b13-b2fb-40a6-a6a6-be2b230bdec9.pdf",
            "news_date": "2025-03-26 17:04:11"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Intimation regarding appointment of Company Secretary and Compliance Officer of the Company under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6c3e0af4-487b-45c7-b7a6-2ac6d472e1ca.pdf",
            "news_date": "2025-03-06 16:53:42"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "General_Announcements",
            "descriptor": "Appointment of Company Secretary / Compliance Officer",
            "caption": "Appointment of Company Secretary and Compliance Officer",
            "news_body": "Intimation regarding appointment of Company Secretary and Compliance Officer of the Company under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9f884dc0-645f-4a47-883f-0be235e8b4bf.pdf",
            "news_date": "2025-03-06 16:47:58"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Outcome",
            "descriptor": "Outcome without intimation",
            "caption": "Board Meeting Outcome for Intimation Regarding Appointment Of Company Secretary And Compliance Officer Of The Company Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Pursuant to Regulation 30 of the Securities and Exchange Board of India (SEBI) (Listing Obligations and Disclosure Requirements) Regulations 2015 read with Para A Part A of Schedule Ill of said Regulations we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. Thursday March 6 2025 based on the recommendation of Nomination and Remuneration Committee approved the appointment of CS Kailash Chand Jethlia(Membership No.: F1476) as Company Secretary and Compliance Officer w.e.f. March 6 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4c953281-a8e2-4031-93dd-caf6520cb172.pdf",
            "news_date": "2025-03-06 16:40:29"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "General_Announcements",
            "descriptor": "Integrated Filing (Financial)",
            "caption": "Integrated Filing (Financial)",
            "news_body": "integrated filing",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=84f7698e-20ba-4907-8bca-73a7f4b9d1f7.pdf",
            "news_date": "2025-02-17 14:14:03"
        },
        {
            "sym": "AAREYDRUGS",
            "disp": "Aarey Drugs & Pharmaceuticals",
            "bse_code": 524412,
            "isin": "INE198H01019",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Result For December 2024",
            "news_body": "Unaudited Financial Result for December 2024",
            "news_id": "051bf214-f027-458a-a456-af82c936964c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=13f5cac2-0ed8-41d6-b995-4557bf963f1c.pdf",
            "news_date": "2025-02-14 19:12:02",
            "seo": "aarey-drugs-pharm-ltd",
            "ltp": 67.97,
            "ch": 2.6400000000000006,
            "pch": 4.041022501148019,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 5245,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Unaudited Financial Result For December 2024",
            "news_body": "Unaudited Financial Result for December 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=13f5cac2-0ed8-41d6-b995-4557bf963f1c.pdf",
            "news_date": "2025-02-14 19:12:02"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome",
            "news_body": "outcome",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=20d03e4f-53fb-4219-afd0-6ee90156da85.pdf",
            "news_date": "2025-02-14 19:06:23"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Quarterly Financial Result",
            "news_body": "AAREY DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 inter alia to consider and approve DEcember Quarterly financial result",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ff54d42b-1772-452a-84f7-84b5d134b73d.pdf",
            "news_date": "2025-02-06 13:02:46"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Reg 74(5) of SEBI (DP) Regulations 2018",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b38847c5-81b4-45fc-8b8c-ba861df2e9fe.pdf",
            "news_date": "2025-01-08 19:01:14"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of Warrants",
            "caption": "Announcement under Regulation 30 (LODR)-Change in RTA",
            "news_body": "Change of RTA name",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=62056fb3-8116-413e-9936-5123be9027bc.pdf",
            "news_date": "2025-01-08 16:48:24"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "General_Announcements",
            "descriptor": "Cessation",
            "caption": "Announcement under Regulation 30 (LODR)-Cessation",
            "news_body": "Reg 30 of SEBI (Listing Obligation and Disclosure Requirements)- Resignation of Company Secretary",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fd6085cd-d4f6-49a3-9363-84279f13e91f.pdf",
            "news_date": "2025-01-02 14:20:27"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Outcome",
            "descriptor": "Outcome without intimation",
            "caption": "Board Meeting Outcome for Outcome",
            "news_body": "Outcome",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c60432a7-eb91-4e00-b03b-525c8e640bd8.pdf",
            "news_date": "2025-01-02 14:10:14"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Outcome",
            "descriptor": "EGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of EGM",
            "news_body": "EGM Proceedings",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46865add-4dcf-43fe-a0e7-ab19c96deaee.pdf",
            "news_date": "2025-01-02 13:47:42"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication corrigendum",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=efce30e4-68b3-41b7-8d8a-332a1deee2d0.pdf",
            "news_date": "2024-12-30 19:57:37"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Corrigendum",
            "news_body": "Corrigendum",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=502c3882-e67f-41a4-b727-f9f6055891d2.pdf",
            "news_date": "2024-12-27 18:10:17"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Company Update",
            "descriptor": "General",
            "caption": "Reg 30 Notice Of General Meeting",
            "news_body": "Reg 30 notice of general meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0ecf1bcf-3fd8-4624-930c-15a54d69559b.pdf",
            "news_date": "2024-12-06 21:29:03"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "AGM/EGM",
            "descriptor": "EGM",
            "caption": "EGM Notice",
            "news_body": "EGM Notice",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dcf43091-5f74-44ed-acd7-eac726fb789f.pdf",
            "news_date": "2024-12-06 21:21:06"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Company Update",
            "descriptor": "Meeting Updates",
            "caption": "Announcement under Regulation 30 (LODR)-Meeting Updates",
            "news_body": "update regarding General  meeting date",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c391c2ed-42ad-4e44-b74e-01ec311affb2.pdf",
            "news_date": "2024-12-04 18:44:26"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Company Update",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Reappointment of Director",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=58b6df16-84ad-4744-ae73-6d53121e1eb0.pdf",
            "news_date": "2024-12-04 18:36:00"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Company Update",
            "descriptor": "Preferential Issue",
            "caption": "Announcement under Regulation 30 (LODR)-Preferential Issue",
            "news_body": "Raising of funds- Preferential issue",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3083e6bf-fa79-44a9-bc9b-ceb032594767.pdf",
            "news_date": "2024-12-04 18:27:34"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Board Meeting",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome",
            "news_body": "Outcome",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8febec79-7633-459c-b7bb-73f0d1e67d8c.pdf",
            "news_date": "2024-12-04 18:22:36"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Insider Trading / SAST",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Closure of Trading Window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=910c29c9-9560-4c92-8abc-7ab513ad8192.pdf",
            "news_date": "2024-11-29 16:33:37"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Board Meeting",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Raising Funds By Way Of Preferential Issue Of Shares Or Warrants Or Any Other Method",
            "news_body": "AAREY DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/12/2024 ,inter alia, to consider and approve Raising funds by way of Preferential issue of shares or warrants or any other method",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=34ae9e69-8413-400a-adab-61b30e517897.pdf",
            "news_date": "2024-11-29 16:20:37"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Board Meeting",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome",
            "news_body": "outcome",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=216a7dc7-f2e4-4a97-a2cd-d9d9d439f94f.pdf",
            "news_date": "2024-11-29 15:17:07"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Insider Trading / SAST",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Closure of trading window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eedbe742-717d-4728-9781-62b2006dd3f8.pdf",
            "news_date": "2024-11-26 16:58:10"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Board Meeting",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Fund Raising",
            "news_body": "AAREY DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/11/2024 ,inter alia, to consider and approve Preferential issue or any other matter",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3540c154-763e-43dd-b45b-99973b4e1c8e.pdf",
            "news_date": "2024-11-26 16:56:22"
        },
        {
            "sym": "AAREYDRUGS",
            "disp": "Aarey Drugs & Pharmaceuticals",
            "bse_code": 524412,
            "isin": "INE198H01019",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Result For September 2024",
            "news_body": "Financial Result for September 2024",
            "news_id": "114b4a8f-604f-4e5f-a116-7f99feac9cff",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4474727d-bd49-4bee-b731-204dc5f2862b.pdf",
            "news_date": "2024-11-14 20:12:47",
            "seo": "aarey-drugs-pharm-ltd",
            "ltp": 67.97,
            "ch": 2.6400000000000006,
            "pch": 4.041022501148019,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 5245,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Result",
            "descriptor": "Financial Results",
            "caption": "Financial Result For September 2024",
            "news_body": "Financial Result for September 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4474727d-bd49-4bee-b731-204dc5f2862b.pdf",
            "news_date": "2024-11-14 20:12:47"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Board Meeting",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome",
            "news_body": "Outcome",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c57923a3-476d-454f-aaee-f1d0654286aa.pdf",
            "news_date": "2024-11-14 20:05:23"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Board Meeting",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Financial Result For September 2024",
            "news_body": "AAREY DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 ,inter alia, to consider and approve Financial result for september 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d1680477-5524-42b8-a4ed-fd4baf11c004.pdf",
            "news_date": "2024-11-06 13:50:22"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Company Update",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "news_body": "Reg 74(5) of SEBI (DP) Regulations, 2018",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f5389833-9d41-4d25-b21b-c862368e33e5.pdf",
            "news_date": "2024-10-08 18:52:56"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Company Update",
            "descriptor": "Allotment of Equity Shares",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment",
            "news_body": "Allotment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=96d8379f-7f10-49d0-a8ac-1f9169c44d00.pdf",
            "news_date": "2024-10-01 14:10:53"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Board Meeting",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome",
            "news_body": "outcome",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4d3690ee-b02e-43ac-ac6f-2c9b9b0c10dd.pdf",
            "news_date": "2024-10-01 14:07:07"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "AGM/EGM",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizer''s Report",
            "news_body": "Scrutinizer Report",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=11b1c957-857e-4f7b-8add-3bd022baadab.pdf",
            "news_date": "2024-10-01 13:30:25"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "AGM/EGM",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
            "news_body": "outcome",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e5439d2f-0cba-4090-9580-68b30e5983e8.pdf",
            "news_date": "2024-09-30 15:53:45"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Board Meeting",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Allotment",
            "news_body": "AAREY DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/10/2024 ,inter alia, to consider and approve Allotment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5be5ccb6-da5f-481f-9b81-bb9eb1879cf5.pdf",
            "news_date": "2024-09-25 13:03:35"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Insider Trading / SAST",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Closure of Trading Window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=02986dc0-647d-448b-915d-47e9c86fcc3b.pdf",
            "news_date": "2024-09-24 17:30:45"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Company Update",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper publication",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fb7b8918-f993-4d08-8658-ecd391ec97e6.pdf",
            "news_date": "2024-09-10 16:00:35"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Company Update",
            "descriptor": "General",
            "caption": "Reg 30 For AGM",
            "news_body": "Reg 30 for AGM",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a43d561e-2c4e-4e49-a125-8daf2a4b37ef.pdf",
            "news_date": "2024-09-06 16:03:09"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Corp. Action",
            "descriptor": "Book Closure",
            "caption": "Book Closure",
            "news_body": "Book closure",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d5d8eb71-a3b0-43cf-a08c-5ef56148da5d.pdf",
            "news_date": "2024-09-06 15:59:25"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "ANNUAL REPORT",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4af87262-68b6-4892-bbae-d107113e83e1.pdf",
            "news_date": "2024-09-06 15:56:37"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Company Update",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b4c5920a-1780-4bf0-80fd-d5ae711cdc18.pdf",
            "news_date": "2024-08-19 11:52:08"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "",
            "descriptor": "Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "news_body": "Issue of Certificate",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8d3d66dd-399c-43af-a191-a8daa09fd91e.pdf",
            "news_date": "2024-08-14 18:02:06"
        },
        {
            "sym": "AAREYDRUGS",
            "disp": "Aarey Drugs & Pharmaceuticals",
            "bse_code": 524412,
            "isin": "INE198H01019",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Result For June 2024",
            "news_body": "Unaudited Financial Result for June 2024",
            "news_id": "d7cb0440-0fd5-497a-a9e2-11ba4449c115",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d6abdc7c-0f31-4567-919a-a4a6b5bf6c59.pdf",
            "news_date": "2024-08-14 17:54:43",
            "seo": "aarey-drugs-pharm-ltd",
            "ltp": 67.97,
            "ch": 2.6400000000000006,
            "pch": 4.041022501148019,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 5245,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Result",
            "descriptor": "Financial Results",
            "caption": "Unaudited Financial Result For June 2024",
            "news_body": "Unaudited Financial Result for June 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d6abdc7c-0f31-4567-919a-a4a6b5bf6c59.pdf",
            "news_date": "2024-08-14 17:54:43"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Board Meeting",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome",
            "news_body": "outcome",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=74090e00-ffd5-4040-8caf-543edb1d8d80.pdf",
            "news_date": "2024-08-14 17:49:02"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Board Meeting",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Unaudited Financial Result For June 2024",
            "news_body": "AAREY DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 ,inter alia, to consider and approve Unaudited Financial Result for June 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aacf28a6-3872-404c-a2bd-fa85c75d6def.pdf",
            "news_date": "2024-08-06 18:06:30"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "",
            "descriptor": "Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "news_body": "Reg 39(3)- Details of Loss of Certificate/ Duplicate Certificate",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aa008291-c6c3-40a9-b09c-68e1f3ee6a1a.pdf",
            "news_date": "2024-07-25 17:41:16"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Company Update",
            "descriptor": "Reg. 32 (1), (3) - Statement of Deviation & Variation",
            "caption": "Reg 32 (1) - Statement Of Deviation And Variation",
            "news_body": "Reg 32(1) - Statement of Deviation and Variation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=826e5c61-91b3-40d0-8bdf-996ff9da99ad.pdf",
            "news_date": "2024-07-22 18:14:06"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Company Update",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "news_body": "Compliance Certificate under Reg 74(5) of SEBI (DP) Regulations, 2018",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=87cd2872-4ff6-4a9c-b8ea-90a08de3e7bf.pdf",
            "news_date": "2024-07-10 07:19:36"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Insider Trading / SAST",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Closure of Trading window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6d212de9-5292-47cf-b1f2-4265355020f5.pdf",
            "news_date": "2024-06-26 18:16:21"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Company Update",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "NEwspaper Publication",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6d8adfa9-6174-4f08-8e4b-39af62135a8a.pdf",
            "news_date": "2024-06-05 13:10:19"
        },
        {
            "sym": "AAREYDRUGS",
            "disp": "Aarey Drugs & Pharmaceuticals",
            "bse_code": 524412,
            "isin": "INE198H01019",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Result For March 2024",
            "news_body": "Audited Financial result for March 2024",
            "news_id": "dfeb83ff-6576-414b-ba36-4bf3c9aa4d2a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c4d54e25-b91a-4ddc-a7be-0b0fd39cd62f.pdf",
            "news_date": "2024-05-30 22:10:31",
            "seo": "aarey-drugs-pharm-ltd",
            "ltp": 67.97,
            "ch": 2.6400000000000006,
            "pch": 4.041022501148019,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 5245,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Result",
            "descriptor": "Financial Results",
            "caption": "Audited Financial Result For March 2024",
            "news_body": "Audited Financial result for March 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c4d54e25-b91a-4ddc-a7be-0b0fd39cd62f.pdf",
            "news_date": "2024-05-30 22:10:31"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Board Meeting",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome",
            "news_body": "outcome",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5620725f-2ed7-4d1b-a226-2ac0aee51e17.pdf",
            "news_date": "2024-05-30 21:59:50"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Company Update",
            "descriptor": "Reg.24(A)-Annual Secretarial Compliance",
            "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
            "news_body": "Reg 24A - Annual Secretarial Compliance Report",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d98587e8-7e6b-4401-947c-4ea9c2845868.pdf",
            "news_date": "2024-05-27 16:08:53"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Board Meeting",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Financial Audited Result Of March 2024",
            "news_body": "AAREY DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 ,inter alia, to consider and approve Financial Audited Result of March 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6b390569-2695-4fa1-a520-cc00cbc42a9a.pdf",
            "news_date": "2024-05-23 18:51:05"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "",
            "descriptor": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure",
            "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A",
            "news_body": "<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>AAREY DRUGS & PHARMACEUTICALS LTD.</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L99999MH1990PLC056538</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr)</td> <td>36.66</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>BBB</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>ACUITE RATINGS & RESEARCH LIMITED</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table>  <br/><br/> <div> <div style=''float:left;''> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No</div> <br/><br/><br/> <div style=''float:left;''> Name of the Company Secretary: Preeti Rathi <br/>  Designation: Company Secretary <br/> EmailId: investorgrievance@aareydrugs.com</div> <div ''style=float:left;margin-left:50px;''> Name of the Chief Financial Officer: Mira Ghatalia <br/> Designation: CFO <br/> EmailId: miraghatalia@gmail.com</div> </div> <div> <br/> Date: 30/04/2024<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=36043df8-8bf1-411b-a8cf-430076467996.pdf",
            "news_date": "2024-04-30 14:52:35"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "",
            "descriptor": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure",
            "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A",
            "news_body": "<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>AAREY DRUGS & PHARMACEUTICALS LTD.</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L99999MH1990PLC056538</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr)</td> <td>36.66</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>BBB</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>ACUITE RATINGS & RESEARCH LIMITED</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table>  <br/><br/> <div> <div style=''float:left;''> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No</div> <br/><br/><br/> <div style=''float:left;''> Name of the Company Secretary: Preeti Rathi <br/>  Designation: Company Secretary <br/> EmailId: investorgrievance@aareydrugs.com</div> <div ''style=float:left;margin-left:50px;''> Name of the Chief Financial Officer: Mira Ghatalia <br/> Designation: CFO <br/> EmailId: miraghatalia@gmail.com</div> </div> <div> <br/> Date: 30/04/2024<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=251e9183-7f2d-49e7-9ac3-a16438c2ada9.pdf",
            "news_date": "2024-04-30 13:06:26"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Company Update",
            "descriptor": "Reg. 7(3) \u2013 Compliance Certificate (RTA & Compliance Officer)",
            "caption": "Reg 7(3)- Compliance Certificate",
            "news_body": "Reg 7(3) - Compliance Certificate",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fd8cbd4c-87df-46f4-a3d1-97e560b355a0.pdf",
            "news_date": "2024-04-18 17:14:20"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Company Update",
            "descriptor": "Reg. 40 (10) - PCS Certificate for Transfer / Transmission / Transposition",
            "caption": "Certificate Under Regulation 40 (9) Of SEBI LODR, Regulations 2015",
            "news_body": "Certificate under Regulation 40(9) of SEBI LODR, Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d5eb46c5-9041-4d5c-933b-1aef0d16cd86.pdf",
            "news_date": "2024-04-15 18:13:51"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Company Update",
            "descriptor": "Reg. 32 (1), (3) - Statement of Deviation & Variation",
            "caption": "Reg 32- Statement Of Deviation",
            "news_body": "Reg 32 - Statement of Deviation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=71c1693e-62d0-428e-9274-fc9c25ab65b4.pdf",
            "news_date": "2024-04-12 07:18:23"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Company Update",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "news_body": "Compliance Certificate under Regulation 74(5)",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bb2fc389-6ef2-4f42-b01c-f2dff9225188.pdf",
            "news_date": "2024-04-10 17:40:26"
        },
        {
            "co_code": 3360,
            "bse_code": 524412,
            "isin": "INE198H01019",
            "ann_type": "Insider Trading / SAST",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Closure of Trading Window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=767191ba-4a46-400d-b6dd-5045c5c05b29.pdf",
            "news_date": "2024-03-29 16:15:57"
        },
        {
            "sym": "AAREYDRUGS",
            "disp": "Aarey Drugs & Pharmaceuticals",
            "bse_code": 524412,
            "isin": "INE198H01019",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Result For December 2023",
            "news_body": "Unaudited financial Result for december 2023",
            "news_id": "02154a0b-9b8d-4568-bb54-383a1041f31b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eb3162f5-d3fd-48c9-92f0-6f23eb81c51d.pdf",
            "news_date": "2024-02-14 18:20:24",
            "seo": "aarey-drugs-pharm-ltd",
            "ltp": 67.97,
            "ch": 2.6400000000000006,
            "pch": 4.041022501148019,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 5245,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AAREYDRUGS",
            "disp": "Aarey Drugs & Pharmaceuticals",
            "bse_code": 524412,
            "isin": "INE198H01019",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Result For December 2023",
            "news_body": "Unaudited Financial Result for December 2023",
            "news_id": "38fe886d-8045-45ca-8d7c-11654fddf505",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aa893b69-4d39-4094-b763-cea7fbb4f156.pdf",
            "news_date": "2024-02-14 16:26:20",
            "seo": "aarey-drugs-pharm-ltd",
            "ltp": 67.97,
            "ch": 2.6400000000000006,
            "pch": 4.041022501148019,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 5245,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AAREYDRUGS",
            "disp": "Aarey Drugs & Pharmaceuticals",
            "bse_code": 524412,
            "isin": "INE198H01019",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Result For September 2023",
            "news_body": "Unaudited financial Result for September 2023",
            "news_id": "f9b696da-5aa7-4cf6-9cf1-fb56a9134981",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6f91e8bd-33ed-4ff2-8239-0af15e671fd6.pdf",
            "news_date": "2023-11-11 16:53:18",
            "seo": "aarey-drugs-pharm-ltd",
            "ltp": 67.97,
            "ch": 2.6400000000000006,
            "pch": 4.041022501148019,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 5245,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AAREYDRUGS",
            "disp": "Aarey Drugs & Pharmaceuticals",
            "bse_code": 524412,
            "isin": "INE198H01019",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Result For June 2023",
            "news_body": "Unaudited Financial Result for June 2023",
            "news_id": "77e1b6a0-5179-4c70-ad3b-c816e0828d19",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e87c1a49-7544-40cc-ac5e-c9e448c5cd03.pdf",
            "news_date": "2023-08-14 14:58:52",
            "seo": "aarey-drugs-pharm-ltd",
            "ltp": 67.97,
            "ch": 2.6400000000000006,
            "pch": 4.041022501148019,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 5245,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AAREYDRUGS",
            "disp": "Aarey Drugs & Pharmaceuticals",
            "bse_code": 524412,
            "isin": "INE198H01019",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Regulation 23(9) Of SEBI (LODR), Regulation 2015",
            "news_body": "Regulation 23(9) of SEBI (LODR), Regulation 2015",
            "news_id": "b7adebf9-4c64-4942-a8b0-1b8110822afe",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8ac2fa95-aa0f-41f7-92bb-d91327e2c906.pdf",
            "news_date": "2023-05-29 20:10:44",
            "seo": "aarey-drugs-pharm-ltd",
            "ltp": 67.97,
            "ch": 2.6400000000000006,
            "pch": 4.041022501148019,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 5245,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AAREYDRUGS",
            "disp": "Aarey Drugs & Pharmaceuticals",
            "bse_code": 524412,
            "isin": "INE198H01019",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Result For The Quarter And Year Ended March 2023.",
            "news_body": "Audited Financial Result for the quarter and year ended March 2023.<BR>",
            "news_id": "c760821b-28de-4a85-aa0e-852107e49c2b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d181df9d-9335-43c8-9ede-8c6e4aa001ae.pdf",
            "news_date": "2023-05-29 18:45:26",
            "seo": "aarey-drugs-pharm-ltd",
            "ltp": 67.97,
            "ch": 2.6400000000000006,
            "pch": 4.041022501148019,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 5245,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AAREYDRUGS",
            "disp": "Aarey Drugs & Pharmaceuticals",
            "bse_code": 524412,
            "isin": "INE198H01019",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Result For The Quarter Ended December 2022.",
            "news_body": "Unaudited Financial Result for the quarter ended December 2022.",
            "news_id": "a063a100-53b2-4629-8d8f-02d9549fe98b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ce18c37b-677b-4660-84ce-02b9f64ffcc9.pdf",
            "news_date": "2023-02-08 17:02:16",
            "seo": "aarey-drugs-pharm-ltd",
            "ltp": 67.97,
            "ch": 2.6400000000000006,
            "pch": 4.041022501148019,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 5245,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AAREYDRUGS",
            "disp": "Aarey Drugs & Pharmaceuticals",
            "bse_code": 524412,
            "isin": "INE198H01019",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting.",
            "news_body": "Outcome of Board meeting",
            "news_id": "4f604300-b998-408d-bf4c-5e22ecb22b5e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ca820cc1-1b47-48b3-b722-16747f6d4378.pdf",
            "news_date": "2023-02-08 16:59:15",
            "seo": "aarey-drugs-pharm-ltd",
            "ltp": 67.97,
            "ch": 2.6400000000000006,
            "pch": 4.041022501148019,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 5245,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AAREYDRUGS",
            "disp": "Aarey Drugs & Pharmaceuticals",
            "bse_code": 524412,
            "isin": "INE198H01019",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Regulation 23(9) Of SEBI (LODR) Regulation 2015.",
            "news_body": "Regulation 23(9) of SEBI (LODR) Regulation 2015.",
            "news_id": "702c5c6d-5370-4de1-b18e-591c3ab49460",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=44afadbb-9232-4530-8eff-b990ab5d6b7f.pdf",
            "news_date": "2022-11-17 15:26:15",
            "seo": "aarey-drugs-pharm-ltd",
            "ltp": 67.97,
            "ch": 2.6400000000000006,
            "pch": 4.041022501148019,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 5245,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AAREYDRUGS",
            "disp": "Aarey Drugs & Pharmaceuticals",
            "bse_code": 524412,
            "isin": "INE198H01019",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Result For The Quarter And Half Year Ended September 2022",
            "news_body": "Unaudited Financial Result for the quarter and half year ended September 2022",
            "news_id": "230c7485-e2c5-416e-aaa9-32cf4233b619",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8fbbd857-de2f-4d5f-b477-24932933a835.pdf",
            "news_date": "2022-11-14 17:33:39",
            "seo": "aarey-drugs-pharm-ltd",
            "ltp": 67.97,
            "ch": 2.6400000000000006,
            "pch": 4.041022501148019,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 5245,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AAREYDRUGS",
            "disp": "Aarey Drugs & Pharmaceuticals",
            "bse_code": 524412,
            "isin": "INE198H01019",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Revised Audited Financial Result For Quarter And Year Ended March 2022.",
            "news_body": "Revised Audited Financial Result for Quarter and year ended March 2022.",
            "news_id": "555721dd-b84f-4fa2-a55f-8150df55d473",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1811aacb-43c3-45a0-80a6-4a8ade4af4dd.pdf",
            "news_date": "2022-08-26 15:49:10",
            "seo": "aarey-drugs-pharm-ltd",
            "ltp": 67.97,
            "ch": 2.6400000000000006,
            "pch": 4.041022501148019,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 5245,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AAREYDRUGS",
            "disp": "Aarey Drugs & Pharmaceuticals",
            "bse_code": 524412,
            "isin": "INE198H01019",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Result For Quarter Ended June 2022.",
            "news_body": "Unaudited Financial Result for quarter ended June 2022.<BR>",
            "news_id": "50f47eab-10ac-4165-8597-68d36a08821e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a3a6b310-33aa-46a2-bd84-ea8d335d3f8b.pdf",
            "news_date": "2022-08-13 16:15:47",
            "seo": "aarey-drugs-pharm-ltd",
            "ltp": 67.97,
            "ch": 2.6400000000000006,
            "pch": 4.041022501148019,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 5245,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AAREYDRUGS",
            "disp": "Aarey Drugs & Pharmaceuticals",
            "bse_code": 524412,
            "isin": "INE198H01019",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Under Regulation 23(9) Of SEBI (Listing Obligation & Disclosure Requiements) , Regulations, 2015",
            "news_body": "Disclosure under Regulation 23(9) of SEBI (Listing Obligation & Disclosure Requiements) , Regulations, 2015",
            "news_id": "ff01ffd4-b337-4a2e-a3e9-e3dd1bcc00cc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=caacaa13-3087-4f30-abaa-351f7dc9c62b.pdf",
            "news_date": "2022-06-09 14:18:43",
            "seo": "aarey-drugs-pharm-ltd",
            "ltp": 67.97,
            "ch": 2.6400000000000006,
            "pch": 4.041022501148019,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 5245,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AAREYDRUGS",
            "disp": "Aarey Drugs & Pharmaceuticals",
            "bse_code": 524412,
            "isin": "INE198H01019",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Result For Year Ended March 2022",
            "news_body": "Audited Financial Result for year ended MArch 2022",
            "news_id": "6b7c73b1-6f9c-48df-bcd9-1aaafd4e19ea",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=068ceed3-1612-4146-93a7-33d9298f0e7a.pdf",
            "news_date": "2022-05-30 18:51:38",
            "seo": "aarey-drugs-pharm-ltd",
            "ltp": 67.97,
            "ch": 2.6400000000000006,
            "pch": 4.041022501148019,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 5245,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AAREYDRUGS",
            "disp": "Aarey Drugs & Pharmaceuticals",
            "bse_code": 524412,
            "isin": "INE198H01019",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Result For Quarter Ended December 2021.",
            "news_body": "Unaudited Financial Result for quarter ended December 2021.",
            "news_id": "ceabd54c-92fa-498d-b213-34561bd2322c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d86eea61-934d-4180-aeae-9d857305a816.pdf",
            "news_date": "2022-02-08 14:44:32",
            "seo": "aarey-drugs-pharm-ltd",
            "ltp": 67.97,
            "ch": 2.6400000000000006,
            "pch": 4.041022501148019,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 5245,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AAREYDRUGS",
            "disp": "Aarey Drugs & Pharmaceuticals",
            "bse_code": 524412,
            "isin": "INE198H01019",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Regulation 23(9) - Disclosure Of Related Party Transaction.",
            "news_body": "Regulation 23(9) - Disclosure of Related Party Transaction.",
            "news_id": "a39f38ca-ff38-4e9c-a75b-e4d52737fee6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=08c9a859-98e9-4c61-9a35-2eb6e5832f19.pdf",
            "news_date": "2021-11-19 17:31:20",
            "seo": "aarey-drugs-pharm-ltd",
            "ltp": 67.97,
            "ch": 2.6400000000000006,
            "pch": 4.041022501148019,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 5245,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AAREYDRUGS",
            "disp": "Aarey Drugs & Pharmaceuticals",
            "bse_code": 524412,
            "isin": "INE198H01019",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Result For The September 2021.",
            "news_body": "Unaudited Financial Result for the September 2021.",
            "news_id": "adf62437-0ad7-4faf-b372-d4aae1b3e208",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ccf8d0b5-76b7-4c3e-8fc2-3c76aff78f00.pdf",
            "news_date": "2021-11-12 16:08:40",
            "seo": "aarey-drugs-pharm-ltd",
            "ltp": 67.97,
            "ch": 2.6400000000000006,
            "pch": 4.041022501148019,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 5245,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AAREYDRUGS",
            "disp": "Aarey Drugs & Pharmaceuticals",
            "bse_code": 524412,
            "isin": "INE198H01019",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Result For June 2021",
            "news_body": "Financial Result for June 2021",
            "news_id": "67d887f1-effb-4a0a-afad-9a7d0dcd972c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6a934689-f6f3-4668-b94d-fa9b8b9fcbaa.pdf",
            "news_date": "2021-08-10 17:39:22",
            "seo": "aarey-drugs-pharm-ltd",
            "ltp": 67.97,
            "ch": 2.6400000000000006,
            "pch": 4.041022501148019,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 5245,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AAREYDRUGS",
            "disp": "Aarey Drugs & Pharmaceuticals",
            "bse_code": 524412,
            "isin": "INE198H01019",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Regulation 23(9) Of SEBI (LODR), Regulations, 2015.",
            "news_body": "Regulation 23(9) of SEBI (LODR), Regulations, 2015.",
            "news_id": "1aef3420-d7c9-4623-ac2f-094b2865e75f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0d452651-b091-4bc7-991a-040748384c73.pdf",
            "news_date": "2021-07-06 14:57:15",
            "seo": "aarey-drugs-pharm-ltd",
            "ltp": 67.97,
            "ch": 2.6400000000000006,
            "pch": 4.041022501148019,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 5245,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AAREYDRUGS",
            "disp": "Aarey Drugs & Pharmaceuticals",
            "bse_code": 524412,
            "isin": "INE198H01019",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Result For March 2021.",
            "news_body": "Financial Result for March 2021.",
            "news_id": "0fdc459b-7af4-40bf-96f6-380daf51918c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3bf9edd3-035e-4dbe-bb02-b0e335feac71.pdf",
            "news_date": "2021-07-03 11:59:57",
            "seo": "aarey-drugs-pharm-ltd",
            "ltp": 67.97,
            "ch": 2.6400000000000006,
            "pch": 4.041022501148019,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 5245,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AAREYDRUGS",
            "disp": "Aarey Drugs & Pharmaceuticals",
            "bse_code": 524412,
            "isin": "INE198H01019",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Result For March 2021.",
            "news_body": "Audited Financial Result for March 2021. Aarey Drugs & Pharmaceuticals Ltd .",
            "news_id": "adb59e8b-bc78-48e2-b61f-82d013ecca30",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6ad9807c-1d93-4700-8537-3249af5feef4.pdf",
            "news_date": "2021-06-29 14:08:58",
            "seo": "aarey-drugs-pharm-ltd",
            "ltp": 67.97,
            "ch": 2.6400000000000006,
            "pch": 4.041022501148019,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 5245,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AAREYDRUGS",
            "disp": "Aarey Drugs & Pharmaceuticals",
            "bse_code": 524412,
            "isin": "INE198H01019",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Result For The Quarter Ended December 2020",
            "news_body": "Unaudited Financial Result for the quarter ended December 2020",
            "news_id": "86b7ecbd-13c1-42fc-9604-4709292976a9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ae222371-aeeb-4218-b9ea-fba8f33fcfbc.pdf",
            "news_date": "2021-02-19 12:50:33",
            "seo": "aarey-drugs-pharm-ltd",
            "ltp": 67.97,
            "ch": 2.6400000000000006,
            "pch": 4.041022501148019,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 5245,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AAREYDRUGS",
            "disp": "Aarey Drugs & Pharmaceuticals",
            "bse_code": 524412,
            "isin": "INE198H01019",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Result For The Quarter Ended December 2020.",
            "news_body": "Unaudited Financial Result for the quarter ended December 2020.",
            "news_id": "9010d00e-9e58-465a-b26c-82e220c1dd31",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=be868f3a-502d-4352-a012-65fcd518b8d0.pdf",
            "news_date": "2021-02-13 15:47:48",
            "seo": "aarey-drugs-pharm-ltd",
            "ltp": 67.97,
            "ch": 2.6400000000000006,
            "pch": 4.041022501148019,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 5245,
            "exch": "NSE",
            "seg": "E"
        }
    ]
}